Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.

(5Z)-7-Oxozeanol and related analogues were isolated and screened to explore their activity as TAK1 inhibitors. Seven analogues were synthesized and more than a score of natural products isolated that examined the role that different areas of the molecule contribute to TAK1 inhibition. A novel nonaromatic difluoro-derivative was synthesized that had similar potency compared to the lead. This is the first example of a nonaromatic compound in this class to have TAK1 inhibition. Covalent docking for the isolated and synthesized analogues was carried out and found a strong correlation between the observed activities and the calculated binding.

[1]  Alexander D. MacKerell,et al.  Position of coordination of the lithium ion determines the regioselectivity of demethylations of 3,4-dimethoxymorphinans with L-selectride. , 2005, Organic letters.

[2]  Gianni Chessari,et al.  Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design. , 2010, Journal of medicinal chemistry.

[3]  G. Ellestad,et al.  New zearalenone related macrolides and isocoumarins from an unidentified fungus , 1978 .

[4]  X. Tian,et al.  Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention. , 2014, Biochemical and biophysical research communications.

[5]  Min Yu,et al.  TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers , 2012, Cell.

[6]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[7]  S. Matthew,et al.  Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships. , 2011, Journal of natural products.

[8]  H. Dohlman,et al.  MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. , 2005, Current opinion in chemical biology.

[9]  Peter G. Dodd,et al.  TAK1 Inhibition in the DFG‐Out Conformation , 2013, Chemical biology & drug design.

[10]  Hong Liu,et al.  Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). , 2014, Chemical reviews.

[11]  J. Ninomiya-Tsuji,et al.  A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase Kinase* , 2003, The Journal of Biological Chemistry.

[12]  Jon Read,et al.  Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. , 2013, ACS chemical biology.

[13]  Y. Zea‐Ponce,et al.  Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter. , 2005, Bioorganic & medicinal chemistry.

[14]  C. Chai,et al.  Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets. , 2011, ACS medicinal chemistry letters.

[15]  F. Gusovsky,et al.  Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory lead. , 2009, Bioorganic & medicinal chemistry letters.

[16]  B. Langlois,et al.  Trifluoromethylation of aromatic compounds with sodium trifluoromethanesulfinate under oxidative conditions. , 1991 .

[17]  Wei Yan,et al.  CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway. , 2015, Biochemical and biophysical research communications.

[18]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[19]  S. Barluenga,et al.  Synthesis of a resorcylic acid lactone (RAL) library using fluorous-mixture synthesis and profile of its selectivity against a panel of kinases. , 2009, Chemistry.

[20]  Kai Zhu,et al.  Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring , 2014, J. Chem. Inf. Model..

[21]  Hong-Hsing Liu,et al.  A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation. , 2009, Blood.

[22]  S. Barluenga,et al.  Molecular Editing of Kinase‐Targeting Resorcylic Acid Lactones (RAL): Fluoroenone RAL , 2010, ChemMedChem.

[23]  S. Barluenga,et al.  In Vivo Efficacy of Natural Product‐Inspired Irreversible Kinase Inhibitors , 2010, Chembiochem : a European journal of chemical biology.

[24]  F. Totzke,et al.  Modular synthesis of radicicol A and related resorcylic acid lactones, potent kinase inhibitors. , 2007, Angewandte Chemie.

[25]  C. Day,et al.  Greensporones: Resorcylic Acid Lactones from an Aquatic Halenospora sp. , 2014, Journal of natural products.

[26]  D. Melisi,et al.  Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. , 2011, Journal of the National Cancer Institute.

[27]  Use of pyrylium synthons in the synthesis of hemispherands with modified cavities. X-ray structures of the 21-hemispherand and a pyrido hemispherand , 1987 .

[28]  A. Kelling,et al.  A Cross‐Metathesis–Conjugate Addition Route to Enantiopure γ‐Butyrolactams and γ‐Lactones from a C2‐Symmetric Precursor , 2011 .

[29]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[30]  R. Reid,et al.  Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides. , 2006, Proceedings of the National Academy of Sciences of the United States of America.